Product Images Nicotine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Nicotine NDC 11822-0873 by Rite Aid Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

NICOTINE LOZENGES - 8739b983c7 f

NICOTINE LOZENGES - 8739b983c7 f

This text appears to be the packaging details for a nicotine product, specifically a 4 mg nicotine polacrilex lozenge. The packaging includes instructions for usage, such as not smoking within 30 minutes of waking up and using the lozenge if you typically smoke your first cigarette within 30 minutes of waking up. It also includes a warning label, dosage information, and the quantity of lozenges in the package.*

NICOTINE LOZENGES - 873b983c7 b

NICOTINE LOZENGES - 873b983c7 b

This text is a drug information sheet on how to use the M Nicotine lozenge to quit smoking. It provides details on the active ingredients, warnings, and directions on how to use the lozenge for the best results and minimize side effects. It also includes a schedule for using the lozenge for up to 12 weeks. Inactive ingredients and contact information for RiteAid are also provided.*

Wallet Card - image 01

Wallet Card - image 01

Wallet Card - image 02

Wallet Card - image 02

The text describes a wallet card that provides information about American Lung Association, American Cancer Society, American Heart Association and a Quitting Buddy or Friend who has Quit. These are contact numbers that can be used to seek help.*

Smoke Free Logo - image 03

Smoke Free Logo - image 03

UPC Example - image 04

UPC Example - image 04

Stickers - image 05

Stickers - image 05

This text appears to be a set of instructions for someone attempting to quit smoking, detailing a schedule for taking lozenges of varying frequency over several weeks. It suggests taking 1 lozenge every 1 to 2 hours on the quit date (beginning of week #1), then gradually reducing the frequency until taking 1 lozenge every 4 to 8 hours at the beginning of week #7. Finally, it recommends taking 1 lozenge every 4 to 8 hours beginning on week #10, which is 12 weeks after the quit date. These instructions are intended to be added to a calendar as reminders.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.